Carcinoma thyroid with blood-borne metastasis is-
**Core Concept**
The question is testing the student's understanding of the prognosis and management of thyroid carcinoma based on its metastatic potential. The American Joint Committee on Cancer (AJCC) staging system is used to classify thyroid cancer based on the extent of its spread, including blood-borne metastasis.
**Why the Correct Answer is Right**
Thyroid carcinoma with blood-borne metastasis is classified as stage IV according to the AJCC staging system. This is because blood-borne metastasis indicates the presence of distant metastases, which significantly worsens the prognosis and requires systemic treatment. The presence of distant metastases also affects the choice of treatment, with a focus on controlling symptoms and improving quality of life rather than achieving a cure.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not accurately reflect the AJCC staging system for thyroid carcinoma. Stage I and II thyroid carcinomas are typically confined to the thyroid gland or have limited extension beyond the gland.
* **Option B:** This option is incorrect because it is too vague and does not accurately reflect the prognosis or management of thyroid carcinoma with blood-borne metastasis.
* **Option C:** This option is incorrect because it does not accurately reflect the AJCC staging system for thyroid carcinoma. Stage III thyroid carcinomas are typically characterized by local invasion or lymph node metastasis.
**Clinical Pearl / High-Yield Fact**
When evaluating a patient with thyroid carcinoma, it is essential to assess for distant metastases, including blood-borne metastasis, as this significantly affects the prognosis and management of the disease. The AJCC staging system provides a framework for classifying thyroid cancer based on its extent of spread.
**Correct Answer:** D.